All
Research
Education
Onderzoek
Onderwijs
Business
Oplossingen
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
Meld u aan
Inst. of Neuroscience and Physiology,
Dept. of Psychiatry and Neurochemistry,
Inst. of Neuroscience and Physiology, Dept. of Psychiatry and Neurochemistry
Johan Gobom has not added Biography.
If you are Johan Gobom and would like to personalize this page please email our Author Liaison for assistance.
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease.
Brain research Nov, 2010 | Pubmed ID: 20875798
An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid.
Journal of mass spectrometry : JMS May, 2012 | Pubmed ID: 22576872
Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.
PloS one , 2012 | Pubmed ID: 22880031
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.
Biomarkers in medicine Aug, 2012 | Pubmed ID: 22917143
A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans.
Alzheimer's research & therapy , 2016 | Pubmed ID: 26948580
Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42 /Aβ1-40 ratio - a cross-validation study against amyloid PET.
Journal of neurochemistry Aug, 2016 | Pubmed ID: 27579672
Expanding the cerebrospinal fluid endopeptidome.
Proteomics Mar, 2017 | Pubmed ID: 28044435
Ex vivo (18)O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway.
Molecular neurodegeneration Feb, 2017 | Pubmed ID: 28219449
A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease.
Scientific reports Oct, 2017 | Pubmed ID: 29042634
Sahlgrenska Academy at University of Gothenburg
Sahlgrenska University Hospital
Karl T. Hansson1,
Tobias Skillbäck1,2,
Elin Pernevik1,
Jessica Holmén-Larsson1,
Gunnar Brinkmalm1,
Kaj Blennow1,2,
Henrik Zetterberg1,2,3,
Johan Gobom1,2
1Inst. of Neuroscience and Physiology, Dept. of Psychiatry and Neurochemistry, Sahlgrenska Academy at University of Gothenburg,
2Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital,
3Department of Molecular Neuroscience, UCL Institute of Neurology
Privacy
Gebruiksvoorwaarden
Beleid
Neem contact met ons op.
Aanbevelen aan bibliotheek
JoVE Nieuwsbrieven
JoVE Journal
Methoden Collecties
JoVE Encyclopedia of Experiments
Archiveren
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
Auteurs
Bibliothecarissen
Toegang
Over JoVE
JoVE Sitemap
Auteursrecht © 2025 MyJoVE Corporation. Alle rechten voorbehouden